PAYER POLICY CHANGES

G0533 Insurance Policy Changes

HCPCS G0533 is officially defined as "Medication assisted treatment, buprenorphine (injectable) administered on a weekly basis; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program)." HCPCS G0533 is referenced in 3 tracked payer policy changes from Medicare/CMS, Kansas Medicaid (KanCare), and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS G0533 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch G0533

Get one email when a payer policy names G0533, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.